Close ties between Trump’s top political nominees and supplement makers could give more leeway to an industry that is lightly regulated, say doctors and public-health experts.
Related Posts
CaixaBank Guides for Weaker Profitability, Resilient Income as Rates Boost Fades
The lender expects a lower return on tangible equity over the next three years as falling interest rates and heavier costs eat into its margins.
Aramco Plans $31 Billion Payout After Profit Beat
Aramco said its second-quarter net profit beat market estimates, and that it planned to pay $31 billion in dividends to the Saudi government and its […]
Louis Vuitton Owner LVMH Misses Revenue Expectations
The French luxury empire said the decline in revenue during the quarter was mainly due to lower growth in Japan.